Company also announces investment in its Deerfield campus; Illinois Lieutenant Governor Sanguinetti serves as honorary chair of race event
Deerfield, IL, October 6, 2017 –Takeda Pharmaceuticals U.S.A., Inc. announced today that it will donate $100,000 to local and regional nonprofits as part of its annual corporate giving fundraiser, Takeda Cares Day. The company also welcomed the Honorable Evelyn Sanguinetti, Lieutenant Governor, State of Illinois, to its corporate offices in Deerfield today to join in the 5K race event around its corporate campus and serve as the honorary chairperson.
As part of the Takeda Cares Day event, employees will run or walk a 5K course around the company’s headquarters in Deerfield to raise money for organizations that support health, science education and community vitality.
“Our corporate giving program, Takeda Cares, underscores our company’s commitment to being a solid corporate citizen,” said Ramona Sequeira, president of Takeda Pharmaceuticals U.S.A., Inc. “Takeda Cares Day celebrates this program and all our year round giving efforts including the hundreds of volunteer hours our employees give to local non profits, charitable donations and grants we provide local, regional and national non profits. It’s a day our employees look forward to as it provides a meaningful opportunity for us to celebrate the positive impact we’re making in our communities and to organizations dedicated to health, science education and community vitality.”
As part of its Takeda Cares Day event, the company’s employees voted to donate $50,000 to the American Red Cross and provide donations of $25,000 each to Mother’s Trust Foundation and Operation Support Our Troops America. In addition to its annual Takeda Cares Day event, Takeda also donates more than $1 million annually to local, regional and national charities.
“These charitable organizations really depend upon corporate support, and it’s great to see one of Chicago’s premier pharmaceutical companies stepping up,” said Evelyn Sanguinetti, Illinois lieutenant governor.
Sanguinetti is the 47th Lieutenant Governor of Illinois and the first Latina to hold that office. She was formerly an adjunct professor of law and a Wheaton City Councilwoman. Following graduation from Florida International University, Sanguinetti moved to Chicago to attend The John Marshall Law School. After graduation, Sanguinetti joined Illinois Attorney General Jim Ryan’s office as an Assistant Attorney General. She was elected to her current position in 2014.
Takeda Also Announces Investment In Deerfield Facilities
Takeda also announced that it plans to make a multi-million dollar investment in renovations and remodeling for its corporate campus in Deerfield, IL. The company has operated from its 70-acre corporate campus in Lake County since 2006, and it serves as the company’s commercial headquarters for its U.S. Business Unit. The facility also houses various global operations roles for Takeda’s marketed products portfolio.
The company said the renovation project is expected to begin in the 3rd quarter, 2017 after an architect is selected. Once the renovation project is underway it should be completed in 18 months. The Takeda corporate campus is comprised of three office buildings and a separate child care facility. In total, the structures comprise more than 628 thousand square feet.
Further, the company said it was time for an update to its campus since it was built more than 10 years ago. It hopes the renovated space will better reflect the way work is increasingly being done by its employees – more collaboration, increased teamwork – and better utilize the existing space.
About 70 percent of Takeda’s Deerfield-based employees live close enough to the suburban campus their commute is less than 30 minutes. Employees can take advantage of such benefits such as onsite daycare, walking/running trail, fitness facilities as well as access to public transportation and outstanding schools and many nearby family-oriented neighborhoods.
The upward business growth of Takeda’s U.S. Business Unit and its established presence as one of the top biopharmaceutical employers in the area has contributed to Takeda earning several national workplace awards—some for up to five consecutive years.
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, R&D-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its research efforts on oncology, gastroenterology and central nervous system therapeutic areas. It also has specific development programs in specialty cardiovascular diseases as well as late-stage candidates for vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology, central nervous system and gastroenterology, as well as its presence in emerging markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries.
For more information, visit http://www.takeda.com/news
About Takeda in the U.S.A.
Takeda Pharmaceuticals U.S.A., Inc. is the U.S. commercial organization of Takeda Pharmaceutical Company Limited. Takeda has a strong commitment to the U.S. with more than 5,000 employees, a significant R&D presence, Oncology and Vaccines headquarters and manufacturing capabilities. Additional information about Takeda Pharmaceuticals U.S.A., Inc. is available through its website, www.takeda.us.
Takeda Pharmaceuticals U.S.A., Inc.